Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The therapies are approved as second or third line treatment for adults with pla...
Jatin Takkar, Head – Product Safety & Regulatory, Siegwerk India argues for a s...
Introduction In 2026, large-scale nutritional surveys continue to reveal a conce...
Rx Propellant, science and R&D infrastructure platform established by Actis, gr...
Excipients are becoming a strategic lever in India’s move toward high-value, gl...
AI is reshaping pharma commercialisation, transforming how companies engage hea...
Under the agreement, Biocodex will hold an exclusive worldwide licence to develo...
The companies plan to jointly develop at least two research and development (R&D...
Nandakumar Kalathil, Country General Manager – India, Agilent Technologies, sha...
Exclusive partnership with Hikma Pharmaceuticals to commercialise product acros...
MVS Omega-3 safety storage handling: For food supplements such as fish oil capsu...
The FDA accepted the gene therapy’s application under the accelerated approval p...
The Takeda-Iambic AI drug discovery collaboration will initially focus on projec...
Collaboration to evaluate AI-led discovery across antibodies, ADCs and gene the...
Platform to coordinate development, manufacturing and supply of SPCs for cardio...
Inspection concluded with no Form 483 observations, company informs stock exch...
